Decoy Therapeutics (DCOY) Operating Income (2015 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Operating Income of -$2.3 million for Q1 2026, down 32.88% year-over-year from -$3.4 million in Q1 2025, and up 74.72% quarter-over-quarter from -$9.0 million in Q4 2025.
Decoy Therapeutics (DCOY) Operating Income (2015 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Operating Income for 12 consecutive years, with -$2.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Income fell 32.88% year-over-year to -$2.3 million; the TTM figure through Mar 2026 stood at -$13.2 million (down 131.97% YoY), while the FY2025 annual figure was -$12.6 million, down 119.97% from the prior year.
- Operating Income rose to -$2.3 million in Q1 2026 per DCOY's latest filing, from -$9.0 million in the prior quarter.
- Across five years, Operating Income topped out at -$895130.0 in Q3 2025 and bottomed at -$14.5 million in Q3 2022.
- Historically, Operating Income has averaged -$3.8 million across 5 years, with a median of -$2.3 million in 2026.
- Annual changes were most pronounced in 2023 — Operating Income surged 85.02% — and 2025, when it sank 506.87%.
- Decoy Therapeutics' Operating Income stood at -$6.5 million in 2022, then soared by 85.02% to -$970701.0 in 2023, then plunged by 53.36% to -$1.5 million in 2024, then tumbled by 506.87% to -$9.0 million in 2025, then jumped by 74.72% to -$2.3 million in 2026.
- Business Quant data shows DCOY's Operating Income at -$2.3 million in Q1 2026, -$9.0 million in Q4 2025, and -$895130.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 231.44 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.55 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 133.12 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -375.75 Mn |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | -2.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.63 Mn |
| Mar 31, 2026 | -2.28 Mn |
| Dec 31, 2025 | -9.03 Mn |
| Sep 30, 2025 | -895,130.00 |
| Jun 30, 2025 | -965,565.00 |
| Mar 31, 2025 | -1.72 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | -1.01 Mn |
| Jun 30, 2024 | -1.47 Mn |
| Mar 31, 2024 | -1.77 Mn |
| Dec 31, 2023 | -970,701.00 |
| Sep 30, 2023 | -2.53 Mn |
| Jun 30, 2023 | -3.97 Mn |
| Mar 31, 2023 | -5.42 Mn |
| Dec 31, 2022 | -6.48 Mn |
| Sep 30, 2022 | -14.49 Mn |
| Jun 30, 2022 | -4.76 Mn |
| Mar 31, 2022 | -6.12 Mn |
| Dec 31, 2021 | -4.14 Mn |
| Sep 30, 2021 | -3.75 Mn |